Thursday, July 13, 2017

Oncogene - Table of Contents alert Volume 36 Issue 28

If you are unable to see the message below, click here to view.


Perfect products for your Cas9 gene editing studies

Diagenode's CRISPR/Cas9 collection

  • Cas9 Nuclease protein NLS
  • Largest collection of Cas9 and Cpf1 antibodies from S. pyogenes and S. aureus
  • Validated Cas9 antibodies for ChIP, IP, WB, IF, and more

Learn more 


Volume 36, Issue 28 (July 2017)

In this issue
Original Articles
Short Communication

Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Celebrating 30 years of Oncogene — 1987 to 2017

Thank you to the editors, board members, contributors, reviewers and readers, past and present for their invaluable contributions, and for bringing the journal to this milestone. 

Watch our anniversary video showing a brief impact overview >>>



Census and evaluation of p53 target genes OPEN

M Fischer

Oncogene 2017 36: 3943-3956; advance online publication, March 13, 2017; 10.1038/onc.2016.502

Abstract | Full Text

FOXC1: an emerging marker and therapeutic target for cancer

B Han, N Bhowmick, Y Qu, S Chung, A E Giuliano and X Cui

Oncogene 2017 36: 3957-3963; advance online publication, March 13, 2017; 10.1038/onc.2017.48

Abstract | Full Text

Original Articles


Targeting Lyn regulates Snail family shuttling and inhibits metastasis

D Thaper, S Vahid, K M Nip, I Moskalev, X Shan, S Frees, M E Roberts, K Ketola, K W Harder, C Gregory-Evans, J L Bishop and A Zoubeidi

Oncogene 2017 36: 3964-3975; advance online publication, March 13, 2017; 10.1038/onc.2017.5

Abstract | Full Text

MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway

L Deng, J Tang, H Yang, C Cheng, S Lu, R Jiang and B Sun

Oncogene 2017 36: 3976-3985; advance online publication, March 13, 2017; 10.1038/onc.2016.491

Abstract | Full Text

MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF OPEN

B Li, W W Xu, L Han, K T Chan, S W Tsao, N P Y Lee, S Law, L Y Xu, E M Li, K W Chan, Y R Qin, X Y Guan, Q Y He and A L M Cheung

Oncogene 2017 36: 3986-4000; advance online publication, March 13, 2017; 10.1038/onc.2017.29

Abstract | Full Text

Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling OPEN

D J Junk, B L Bryson, J M Smigiel, N Parameswaran, C A Bartel and M W Jackson

Oncogene 2017 36: 4001-4013; advance online publication, March 13, 2017; 10.1038/onc.2017.33

Abstract | Full Text

Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression OPEN

R Gupta, Q Yang, S K Dogra and N Wajapeyee

Oncogene 2017 36: 4014-4024; advance online publication, March 13, 2017; 10.1038/onc.2017.37

Abstract | Full Text

Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome OPEN

G V Walls, M Stevenson, K E Lines, P J Newey, A A C Reed, M R Bowl, J Jeyabalan, B Harding, K J Bradley, S Manek, J Chen, P Wang, B O Williams, B T Teh and R V Thakker

Oncogene 2017 36: 4025-4036; advance online publication, March 13, 2017; 10.1038/onc.2017.43

Abstract | Full Text

MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer

A Bouillez, H Rajabi, C Jin, M Samur, A Tagde, M Alam, M Hiraki, T Maeda, X Hu, D Adeegbe, S Kharbanda, K-K Wong and D Kufe

Oncogene 2017 36: 4037-4046; advance online publication, March 13, 2017; 10.1038/onc.2017.47

Abstract | Full Text

CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis

X Hu, Y Zhao, L Wei, B Zhu, D Song, J Wang, L Yu and J Wu

Oncogene 2017 36: 4047-4059; advance online publication, March 20, 2017; 10.1038/onc.2017.10

Abstract | Full Text

CAMK2γ in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation

X Ma, Z Meng, L Jin, Z Xiao, X Wang, W M Tsark, L Ding, Y Gu, J Zhang, B Kim, M He, X Gan, J E Shively, H Yu, R Xu and W Huang

Oncogene 2017 36: 4060-4071; advance online publication, March 20, 2017; 10.1038/onc.2017.16

Abstract | Full Text

FOXA1 inhibits prostate cancer neuroendocrine differentiation

J Kim, H Jin, J C Zhao, Y A Yang, Y Li, X Yang, X Dong and J Yu

Oncogene 2017 36: 4072-4080; advance online publication, March 20, 2017; 10.1038/onc.2017.50

Abstract | Full Text

Short Communication


CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner OPEN

L Huang, Z Wang, C Liu, C Xu, R M Mbofung, J A McKenzie, H Khong, P Hwu and W Peng

Oncogene 2017 36: 4081-4086; advance online publication, March 6, 2017; 10.1038/onc.2017.35

Abstract | Full Text



Manganese superoxide dismutase deficiency triggers mitochondrial uncoupling and the Warburg effect

Y Xu, S Miriyala, F Fang, V Bakthavatchalu, T Noel, D M Schnell, C Wang, W H St Clair and D K St Clair

Oncogene 2017 36: 4087; advance online publication, March 13, 2017; 10.1038/onc.2016.513

Full Text

Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial–mesenchymal transition OPEN

Q Zhang, T Wei, K Shim, K Wright, K Xu, H L Palka-Hamblin, A Jurkevich and S Khare

Oncogene 2017 36: 4088; advance online publication, March 13, 2017; 10.1038/onc.2017.56

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: